PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32798558-8	2020	KEY FINDINGS: Results from humans showed that anesthesia with Dex decreased the number of both CD68 positive cells and CD86 positive cells and down-regulated level of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha) and monocyte chemotactic protein 1 (MCP-1) in human lung.	Dexmedetomidine	62-65	C-C motif chemokine ligand 2	Homo sapiens	238-268	
32798558-8	2020	KEY FINDINGS: Results from humans showed that anesthesia with Dex decreased the number of both CD68 positive cells and CD86 positive cells and down-regulated level of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha) and monocyte chemotactic protein 1 (MCP-1) in human lung.	Dexmedetomidine	62-65	C-C motif chemokine ligand 2	Homo sapiens	270-275	
28286770-0	2017	Dexmedetomidine Attenuates Lipopolysaccharide Induced MCP-1 Expression in Primary Astrocyte.	Dexmedetomidine	0-15	C-C motif chemokine ligand 2	Homo sapiens	54-59	
28286770-4	2017	This study aimed to investigate the potential effects of DEX on the production of MCP-1 in lipopolysaccharide-stimulated astrocytes.	Dexmedetomidine	57-60	C-C motif chemokine ligand 2	Homo sapiens	82-87	
28286770-10	2017	Administration of DEX significantly inhibited the expression of MCP-1 mRNA (P < 0.001).	Dexmedetomidine	18-21	C-C motif chemokine ligand 2	Homo sapiens	64-69	
28286770-13	2017	DEX is a potent suppressor of MCP-1 in astrocytes induced with lipopolysaccharide through alpha2A-adrenergic receptors, which potentially explains its beneficial effects in the treatment of delirium by attenuating neuroinflammation.	Dexmedetomidine	0-3	C-C motif chemokine ligand 2	Homo sapiens	30-35